Raleigh, NC (PRWEB) November 04, 2015 -- A London-based mesothelioma researcher says current studies are insufficient to help doctors and mesothelioma patients make informed decisions about surgery. Surviving Mesothelioma has more on the new article. Click here to read it now.
Dr. Tom Treasure, a professor in the Clinical Operational Research Unit at University College London, says what the medical community needs are more randomized, independently run multicenter trials on mesothelioma surgery.
“Because of the nature of the disease and the multiplicity of treatment protocols, defining the direction and magnitude of a survival difference cannot be determined from personal experience, follow-up studies or other methods lacking rigorous control data,” writes Dr. Treasure.
Dr. Treasure’s article in the Journal of Thoracic and Cardiovascular Surgery notes the ongoing division among surgeons over extrapleural pneumonectomy (EPP) and pleurectomy/decortication (P/D) for mesothelioma.
“There are so many difficult decisions to make after a diagnosis of mesothelioma,” says Surviving Mesothelioma Managing Editor Alex Strauss. “We would hope that new randomized studies could help ease the decision-making process a little when it comes to mesothelioma surgery.”
For more on Dr. Treasure’s conclusions and an explanation of the two major approaches to mesothelioma surgery, see What is the Best Approach to Surgery for Mesothelioma?, now available on the Surviving Mesothelioma website.
Treasure, T, “What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice”, September 28, 2015, Journal of Thoracic and Cardiovascular Surgery, Epub ahead of print, http://www.jtcvsonline.org/article/S0022-5223(15)01795-X/abstract
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.
Michael Ellis, Cancer Monthy, http://www.survivingmesothelioma.com, +1 (919) 570-8595, [email protected]
SOURCE Cancer Monthy